The Prevention and Treatment of the Abuse of Illicit Drugs

  • John JoshuaEmail author


This chapter discusses the prevention and treatment of the abuse of illicit drugs and begins with a description of programs such as the methadone maintenance treatment program, the heroin maintenance program, and harm minimization programs. It is argued that such programs should include vocational counselling as part of the rehabilitation programs. The creation of special drug courts may be seen as an alternative to the more common present criminal justice system to enable the integration of the judicial and criminal justice system together with the treatment of drug abuse and rehabilitation. The chapter then concludes with a discussion of an effective scientifically oriented drug policy. It is argued that a viable drug policy should be based on scientific and empirical evidence.


Drug courts Effectiveness of programs Harm minimization Health effects Maintenance programs Programs of intervention Rehabilitation Scientifically oriented drug policies 


  1. Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioural change. Psychological Review, 84(2), 191–215.CrossRefGoogle Scholar
  2. Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W.H. Freeman.Google Scholar
  3. Barnett, P. G. (2009). Comparison of costs and utilization among buprenorphine and methadone patients. Addiction, 104(6), 982–992.CrossRefGoogle Scholar
  4. Boaz, D. (1990). The consequences of prohibition. In D. Boaz (Ed.), The crisis of drug prohibition. Cato Institute: Washington.Google Scholar
  5. Callahan, E. J. (1980). Alternative strategies in the treatment of narcotic addiction: A review. In W. R. Miller (Ed.), The addictive behaviors: Treatment of alcoholism, drug abuse, smoking, and obesity. New York: Pergamon.Google Scholar
  6. Cartwright, W. S. (2000). Cost-benefit analysis of drug treatment services: Review of the literature. Journal of Mental Health Policy and Economics, 3(1), 11–26.CrossRefGoogle Scholar
  7. Clague, C. (1973). Legal strategies for dealing with heroin addiction. American Economic Review, 63(2), 263–269.Google Scholar
  8. Cook, P. J., & Reuter, P. (2007). When is alcohol just another drug. Some thoughts on research and policy. Addiction, 102(8), 1183–1188.CrossRefGoogle Scholar
  9. Coviello, D. M., Zanis, D. A., et al. (2009). An integrated drug counselling and employment intervention for methadone clients. Journal of Psychoactive Drugs, 41(2), 189–197.CrossRefGoogle Scholar
  10. Doessel, D. P., & Williams, R. F. G. (2008). The simple analytics of illicit drug policy. The Australian Economic Review, 41(3), 239–249.CrossRefGoogle Scholar
  11. Ellickson, P. L., Bui, K., et al. (1998). Does early drug use increase the risk of dropping out of high school? Journal of Drug Issues, 28, 357–380.CrossRefGoogle Scholar
  12. French, M. T., Salome, H. J., et al. (2002). Benefit-cost analysis of addiction treatment: Methodological guidelines and empirical application using the DATCAP and ASI. Health Services Research, 37(2), 433–455.CrossRefGoogle Scholar
  13. Godfrey, C., Stewart, D., et al. (2004). Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the national treatment outcome research study (NTORS). Addiction, 99(6), 697–707.CrossRefGoogle Scholar
  14. Goodwin, L. R., & Sias, S. M. (2014). Severe substance use disorder viewed as a chronic condition and disability. Journal of Rehabilitation, 80(4), 42–49.Google Scholar
  15. Jofre-Bonet, M., & Sindelar, J. L. (2004). Creating an aggregate outcome index: Cost-effectiveness analysis of substance abuse treatment. Journal of Behavioral Health Services & Research, 31(3), 229–241.CrossRefGoogle Scholar
  16. King, R. S., & Pasquarella, J. (2009). Drug courts: A review of the evidence. Washington: The Sentencing Project.Google Scholar
  17. Klag, S., O’Callaghan, F., et al. (2005). The use of legal coercion in the treatment of substance abusers: An overview and critical analysis of thirty years of research. Substance Use and Misuse, 40(12), 1777–1795.CrossRefGoogle Scholar
  18. Li, J., & Li, X. (2013). Current status of drug use and HIV/AIDS prevention in drug users in China. Journal of Food & Drug Analysis, 21, S37–S41.CrossRefGoogle Scholar
  19. Lu, M. & McGuire, T.G. (2002). The productivity of Outpatient Treatment for Substance Abuse. The Journal of Human Resources, xxxvii(2), 309–335.Google Scholar
  20. Lutze, F. E., & van Wormer, J. (2007). The nexus between drug and alcohol treatment program integrity and drug court effectiveness. Criminal Justice Policy Review, 18(3), 226–245.CrossRefGoogle Scholar
  21. MacCoun, R.J., & Reuter, P. (2001). Drug war heresies. Learning from other vices, times and places. Cambridge: Cambridge University Press.Google Scholar
  22. Marks, R. (1990). Prohibition or regulation: An economist’s view of Australia heroin policy. Australian and New Zealand Journal of Criminology, 23, 65–87.CrossRefGoogle Scholar
  23. Masson, C. L., Barnett, P. G., et al. (2004). Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180 day methadone detoxification. Addiction, 99(6), 718–726.CrossRefGoogle Scholar
  24. McCluskey, C. P., Krohn, M. D., et al. (2002). Early substance use and school achievement: An examination of Latino, white, and African American youth. Journal of Drug Issues, 32, 921–944.CrossRefGoogle Scholar
  25. McLellan, A. T., Lewis, D. C., et al. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association, 284(13), 1689–1695.CrossRefGoogle Scholar
  26. Miller, S. M., & Moulton, S. (2014). Publicness in policy environments: A multilevel analysis of substance abuse treatment services. Journal of Public Administration Research and Theory, 23(3), 553–589.CrossRefGoogle Scholar
  27. Miron, J. A. (1999). Violence and the US prohibitions of drugs and alcohol. American Law and Economics Review, 1(1), 78–114.CrossRefGoogle Scholar
  28. Miron, J. A., & Zwiebel, J. (1995). The economic case against drug prohibition. Journal of Economic Perspectives, 9(4), 175–192.CrossRefGoogle Scholar
  29. Moeller, K. (2012). Costs and revenues in street-level cannabis dealing. Trends in Organized Crime, 15(1), 31–46.CrossRefGoogle Scholar
  30. Paoli, L. (2001). Illegal drug trade in Russia. Project commissioned by the United Nations office for drug control and crime prevention. Freiburg: Max Planck Institute for Foreign and International Penal Law.Google Scholar
  31. Pudney, S. (2010). Drugs policy: What should we do about cannabis? Economic Policy, 167–211. Institute for Social and Economic Research, University of Essex.Google Scholar
  32. Rettig, R. A., & Yarmolinski, A. (1995). Federal regulation of methadone treatment. Washington, DC: National Academy Press.Google Scholar
  33. Reuter, P. (2009). Ten years after the United Nations General Assembly Special Session (UNGASS): Assessing drug problems, policies and reform proposals. Addiction, 104(4), 510–517.CrossRefGoogle Scholar
  34. Rydell, C. P., Caulkins, J. P., & Everingham, S. S. (1996). Enforcement or treatment? Modelling the relative efficacy of alternatives for controlling cocaine. Operations Research, 44, 1–9.CrossRefGoogle Scholar
  35. Saffer, H., Chaloupka, F., & Dave, D. (2001). State drug control spending and illicit drug participation. Contemporary Economic Policy, 19(2), 150–161.CrossRefGoogle Scholar
  36. Shanahan, M. D., Doran, C. M., et al. (2006). A cost-effectiveness analysis of heroin detoxification methods in the Australian national evaluation of pharmacotherapies for opioid dependence (NEPOD). Addictive Behaviour, 31(3), 371–387.CrossRefGoogle Scholar
  37. Stimson, G. V. (1995). Aids and injecting drug use in the United Kingdom, 1987–1993: The policy response and the prevention of the epidemic. Social Science and Medicine, 41, 699–716.CrossRefGoogle Scholar
  38. Stimson, G. V. (1998). Harm reduction in action: Putting theory into practice. International Journal of Drug Policy, 9, 401–409.CrossRefGoogle Scholar
  39. Wodak, A., & Lurie, P. (1997). A tale of two countries: Attempts to control HIV among injecting drug users in Australia and the United States. Journal of Drug Issues, 27(1), 117–134.CrossRefGoogle Scholar
  40. World Health Organization. (1992). International classification of diseases—10th revision. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.Google Scholar
  41. Zaric, G. S., Brandeau, M. L., et al. (2000). Methadone maintenance and HIV prevention: A cost-effectiveness analysis. Management Science, 46(8), 1013–1031.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.Deakin UniversityMelbourneAustralia

Personalised recommendations